Novel Approach to Enhance Neuromuscular Function in Patients with Duchenne Muscular Dystrophy (IMAGE)
Caption
A new study in The American Journal of Pathology identifies the enzyme glutamate dehydrogenase 1 (GLUD1) as a potential therapeutic target for muscle restoration in Duchenne muscular dystrophy. Shown here is a schematic illustration of the therapeutic effects of pharmacological GLUD1 blockade in dystrophic muscle fibers and macrophages.
Credit
The American Journal of Pathology / Pereira-Nunes et al.)
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND